Autopsy report · NCT00329485

The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients

“Poor recruitment and through put”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 1 month before it stopped.
• 120 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Valen Labs

Sponsor type

Industry

Conditions

Congestive Heart Failure

Interventions

CORvalen (D-Ribose)

Participants

120

Sites

1

Countries

United States

Trials that died the same way

• A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
  “Poor recruitment” (82% match in meaning)
• Pilot RCT Evaluating a One Stop Vein Clinic
  “Very poor recruitment” (80% match in meaning)
• Prospective Evaluation of Quality of Life in Patients With Acute Colonic Diverticular Disease
  “poor recruitment status” (79% match in meaning)
• Intrauterine Device Insertion Pain Management
  “Inadequate recruitment” (77% match in meaning)
• Primary Care-Based Physical Activity for Diabetic Latinas
  “poor recruitment \& retention” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.